Vertical: CNMBase Year: 2025
Market Size (2025)
$546.15M
Projected (2032)
$1.06B
CAGR (2022–2032)
9.9%
Key Players
11+
Market Overview
The global biochemical pesticides market was valued at USD 546.16 Million in 2025 and is projected to reach USD 1,057.57 Million by 2032, registering a CAGR of 9.89% during 2026–2032. The market has expanded steadily from USD 409.82 Million in 2022, and the forecast implies an absolute increase of USD 511.41 Million between 2025 and 2032, nearly doubling the size of the market over the forecast horizon.
Biochemical pesticides are naturally occurring substances, or synthetic substances structurally similar and functionally identical to them, that control pests through non-toxic modes of action such as mating disruption, attraction, repellence, feeding deterrence and the induction of plant defence. The category occupies a distinct position within biological crop protection: it is regulated separately from microbial pesticides in the United States, and many of its active substances qualify for simplified or low-risk regulatory treatment in other jurisdictions. Demand is anchored in high-value specialty crops, where residue limits, export requirements and resistance management create strong incentives to replace or supplement synthetic chemistry, and it is broadening into row crops as lower-cost pheromone manufacturing and sprayable formulations come to market.
Key Findings
Product type: Pheromones & Semiochemicals and Plant Extracts held equal shares of 35.00% each in 2025 (USD 191.15 Million each). Pheromones & Semiochemicals is the fastest-growing product type, with a CAGR of 11.66%, and is projected to reach USD 414.57 Million by 2032, making it the single largest product type by the end of the forecast period.
Crop type: Fruits & Vegetables is the largest crop type, accounting for 60.00% of the market (USD 327.69 Million) in 2025. Cereals & Grains is the fastest-growing crop type, with a CAGR of 11.70% over 2026–2032.
Region: North America is the leading region, with 33.00% of the global market (USD 180.23 Million) in 2025. Asia Pacific is the fastest-growing region, with a CAGR of 12.42%, rising from USD 98.31 Million in 2025 to USD 223.68 Million in 2032.
Country: The U.S. is the leading country market, valued at USD 147.79 Million in 2025 and projected to reach USD 256.83 Million by 2032. India is the fastest-growing country, with a CAGR of 14.11% during 2026–2032.
Segmentation Summary
The market is analysed by product type (Pheromones & Semiochemicals, Plant Extracts and Others), by crop type (Fruits & Vegetables, Cereals & Grains and Others) and by region (North America, Europe, Asia Pacific, Latin America and Middle East & Africa), with country-level analysis within each region. Pheromones & Semiochemicals benefit from the maturity of mating disruption in orchards and vineyards and from the entry of fermentation-derived pheromones into row crops. Plant Extracts retain a broad base across emerging markets and organic production. The Others category, which covers the remaining naturally occurring substances, grows more slowly at a CAGR of 6.87%.
Competitive Landscape Summary
The market is moderately fragmented. Pheromone active-ingredient manufacturing is concentrated among a limited number of specialised producers, led by Shin-Etsu Chemical and Suterra, while plant-extract products are supplied by a larger number of regional manufacturers. Diversified crop protection companies, including FMC Corporation, BASF, Bayer and Syngenta, participate through acquisitions, in-house pheromone ranges and distribution partnerships with specialists such as M2i Life Sciences and Provivi. Competition centres on registered product breadth, dispenser and formulation technology, cost per hectare and access to growers through distribution networks.
Challenges and Opportunities
The principal challenges are higher per-hectare cost than many synthetic insecticides, narrower pest spectra, the need for area-wide deployment for mating disruption to be effective, and registration processes that remain lengthy in several emerging markets. Opportunities lie in extending pheromones to large-acreage crops such as maize, rice and cotton, in regulatory reforms that favour low-risk and biological inputs (such as Brazil's bioinputs law and the European Union's low-risk active substance provisions), and in residue-free programmes demanded by food retailers and export markets.
Future Outlook
The market is expected to grow from USD 600.72 Million in 2026 to USD 1,057.57 Million in 2032. Growth leadership shifts progressively towards Asia Pacific, Latin America and Middle East & Africa, which record CAGRs of 12.42%, 10.65% and 11.45% respectively, compared with 8.46% for North America and 8.70% for Europe. Product innovation in low-cost biomanufactured pheromones, sprayable and aerosol delivery systems, and combination products that pair attractants with natural insecticides is expected to broaden adoption beyond the specialty crops in which biochemical pesticides are already established.
The Biochemical Pesticides Market market is projected to grow at a CAGR of 9.9% from 2022 to 2032.
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansSubscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansDefinition
Biochemical pesticides are naturally occurring substances that control pests by non-toxic mechanisms. Under the United States regulatory framework (40 CFR Part 158, Subpart U), a biochemical pesticide must be a naturally occurring substance, or structurally similar and functionally identical to a naturally occurring substance, and must have a non-toxic mode of action towards the target pest. Unlike conventional pesticides, which typically kill or inactivate pests through direct toxicity, biochemical pesticides act by interfering with mating, attracting pests to traps, repelling or deterring feeding, regulating growth, or stimulating plant defence responses.
Included in the scope:
Pheromones and other semiochemicals, including sex pheromones, aggregation pheromones, kairomones and allomones used for mating disruption, mass trapping, attract-and-kill and monitoring-linked control.
Plant extracts and plant-derived oils with pesticidal activity, such as neem (azadirachtin) preparations, essential-oil based products and extracts that induce plant resistance.
Other naturally occurring biochemical substances, such as natural plant growth regulators, naturally derived insect growth regulators, and other biochemical actives registered for pest control.
Excluded from the scope:
Microbial pesticides based on bacteria, fungi, viruses or protozoa, and their fermentation-based whole-cell products.
Macrobials, such as beneficial insects, mites and entomopathogenic nematodes, and plant-incorporated protectants.
Conventional synthetic pesticides, and biostimulants or biofertilisers sold without a pest control claim.
Scope of the Study
The study covers the global biochemical pesticides market by product type, crop type and region. Market values are presented in USD Million for the historic years 2022, 2023 and 2024, the base year 2025 and the forecast years 2026 to 2032. Compound annual growth rates are presented for 2026–2032.
Research Objectives
To estimate the size of the global biochemical pesticides market for 2022–2025 and forecast it for 2026–2032 in USD Million.
To analyse the market by product type, covering Pheromones & Semiochemicals, Plant Extracts and Others, and identify the segments with the strongest growth potential.
To analyse the market by crop type, covering Fruits & Vegetables, Cereals & Grains and Others, and assess how adoption differs between specialty and row crops.
To evaluate regional and country-level demand across North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
To assess the drivers, restraints, opportunities, trends and challenges influencing the adoption of biochemical pesticides, including the effect of regulatory reforms on synthetic and low-risk crop protection products.
To examine the value chain, competitive forces, regulatory landscape and macro-environmental factors that shape the market.
To identify the leading companies, assess their positioning and capabilities, and track key developments such as acquisitions, partnerships, product registrations and launches since 2022.
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansSubscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansSubscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansOverview of the Research Process
The study follows a structured research process combining secondary research, primary research, market size estimation, data triangulation and forecasting. The process begins with defining the market boundary and segmentation, followed by the collection of qualitative and quantitative information from published sources. These inputs are then tested and refined through discussions with industry participants. Market estimates are developed using both top-down and bottom-up approaches, reconciled through triangulation, and projected over the forecast period using a factor-based forecasting model. The final estimates are reviewed for internal consistency across product types, crop types, regions and countries.
Secondary Research
Secondary research was used to establish the market definition, identify industry participants, understand product and regulatory developments, and gather data points for market sizing. The principal source types are:
Government and regulatory bodies: pesticide registration databases and publications of agencies such as the U.S. Environmental Protection Agency (including its Biopesticides and Pollution Prevention Division), the European Commission and the European Food Safety Authority, India's Central Insecticides Board & Registration Committee, Health Canada's pest management regulator, Brazil's Ministry of Agriculture and Livestock, and Australia's APVMA.
Industry associations: publications of biological crop protection associations such as the Biological Products Industry Alliance (BPIA), the International Biocontrol Manufacturers Association (IBMA) and national crop protection associations.
Company sources: annual reports, investor presentations, press releases, product labels and registration notices of manufacturers and distributors.
Trade journals and scientific literature: agricultural trade publications and peer-reviewed research on semiochemicals, botanical pesticides and integrated pest management.
International organisations and statistical databases: agricultural production and crop area statistics from FAO and national statistical agencies, organic agriculture statistics, and trade data.
Paid databases: company financial databases, news aggregators and agricultural market intelligence services.
Primary Research
Primary research was conducted to validate secondary findings, fill information gaps and obtain qualitative insight into market dynamics. Discussions were held through telephone and online interviews and structured questionnaires with participants across the value chain.
Supply side: executives, product managers, regulatory affairs specialists and business development managers at pheromone producers, plant-extract manufacturers, formulators, diversified crop protection companies and distributors.
Demand side: commercial growers of fruits, vegetables, cereals and other crops, crop consultants and pest control advisers, cooperatives, agri-input retailers and procurement managers at food companies with residue management programmes.
The objectives of primary research were to verify market size and segment splits, understand pricing and per-hectare treatment costs, assess adoption barriers, identify emerging products and pipeline registrations, and gauge expectations for growth over the forecast period.
Market Size Estimation
Top-down approach: The overall crop protection and biological crop protection markets were used as the starting point. The share attributable to biochemical pesticides was derived from company revenues, registration data and expert input, and then allocated to product types, crop types, regions and countries using adoption rates and crop area data.
Bottom-up approach: Revenues of leading companies from relevant biochemical pesticide products were estimated and aggregated, and adjusted for the share of smaller and regional suppliers. In parallel, demand-side estimates were built from treated area by crop and region, application rates and average product prices.
Data triangulation: The results of the top-down and bottom-up approaches were compared and reconciled. Differences were investigated through additional secondary research and primary discussions until a consistent estimate was reached for each segment, region and country.
Forecasting Methodology
The forecast was developed by projecting the base-year market using growth factors specific to each segment and region. The factors considered include crop area and crop value trends, pest pressure and resistance development, regulatory changes affecting synthetic and biological crop protection products, growth in organic and residue-managed production, new product registrations and launches, price trends, and macroeconomic indicators such as agricultural GDP and farm income. Each factor was weighted according to its expected influence in the short, medium and long term, and the resulting growth rates were validated with industry participants.
Assumptions and Limitations
Market values are expressed in nominal USD at constant exchange rates; currency fluctuations over the forecast period are not separately modelled.
The regulatory frameworks in force in the base year are assumed to continue, with announced reforms taken into account as they are scheduled to take effect.
No major disruption to global agricultural trade, such as a severe pandemic or prolonged trade embargo, is assumed over the forecast period.
Many participants in the market are privately held or report biochemical pesticide revenues within broader segments; estimates for these companies rely on secondary information and expert input.
Product classification follows the market definition in Section 2.1; products with mixed microbial and biochemical actives are allocated according to their principal active ingredient.
Country-level estimates for smaller markets grouped under "Rest of" categories are based on aggregated data and are subject to a wider margin of uncertainty.
Base Year
2025
Historical Period
2022 – 2024
Forecast Period
2026 – 2032
Primary Interviews
150+
Historical data (2022–2025) and forecast period (2025–2032)
Our research process spans primary interviews with industry stakeholders combined with comprehensive secondary data analysis, validated through triangulation across multiple independent sources.
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansIntroduction
The global biochemical pesticides market is moderately fragmented. The pheromones and semiochemicals segment is relatively concentrated at the active ingredient level, where a small number of companies with proprietary synthesis capability, such as Shin-Etsu Chemical, Suterra and M2i Life Sciences, supply a large share of the products used in orchards, vineyards and tree nuts, often through regional distribution partners. The plant extracts segment is more fragmented, with many regional and national producers, particularly in India, China and Southern Europe, alongside specialist biological companies.
Competition is based on the breadth of registered products and pest targets, dispenser and formulation technology, cost per hectare, technical support to growers and access to distribution channels. Diversified crop protection companies, including FMC Corporation, BASF, Bayer and Syngenta, have strengthened their positions through acquisitions, in-house pheromone ranges and exclusive distribution agreements with specialists. Smaller innovators, such as Provivi, compete through new production technologies aimed at large-acreage row crops and commercialise largely through partners. In addition to the companies assessed in this chapter, the market includes specialist semiochemical companies such as Pacific Biocontrol, ISCA, Trécé and Russell IPM, and botanical product suppliers serving regional markets.
Key Player Positioning
Leaders: Shin-Etsu Chemical and Suterra are the leading companies in the pheromone segment. Shin-Etsu manufactures pheromone actives and dispensers, sold under brands such as Confuser in Japan, Isomate in the Americas through Pacific Biocontrol, and Isonet in Europe through CBC's Biogard division. Suterra, a division of The Wonderful Company, offers the CheckMate mating disruption range, Puffer aerosol dispensers and attract-and-kill products, and broadened its portfolio in 2026 with the acquisition of Vestaron's product lines.
Challengers: FMC Corporation, BASF, Bayer, M2i Life Sciences, Syngenta and CBC are challengers. BASF has a long-established RAK pheromone range for grapes and fruit. FMC entered the segment through the acquisition of BioPhero and launched its Sofero pheromones for fall armyworm from 2025. Bayer combines its own Vynyty Citrus device with exclusive global distribution of M2i pheromone gels, giving M2i broad market access. Syngenta is building its position through partnerships and natural product discovery, while CBC is a major European distributor and registrant of pheromone products.
Niche players: Provivi, Pro Farm Group and Seipasa occupy niche positions. Provivi focuses on low-cost pheromones for maize and rice in emerging markets. Pro Farm Group, formerly Marrone Bio Innovations, offers the REGALIA plant-extract product, although its ownership has been in transition since 2026. Seipasa offers botanical bio-insecticides with registrations focused on Mediterranean and Latin American markets.
Competitor Dashboard
The competitor dashboard rates each company on four parameters: the breadth of its biochemical pesticide product portfolio, its regional presence, its strategic alliances and its experience in the industry. Ratings are qualitative analyst assessments.
Threat of New Entrants: Medium
Simplified data requirements for biochemical substances in some jurisdictions and venture capital interest in biological crop protection lower the barriers for start-ups.
Proprietary synthesis and fermentation know-how, dispenser technology and the cost and time of multi-country registration remain significant barriers.
Access to growers depends on established distribution networks, which new entrants usually obtain through partnerships with larger companies.
Bargaining Power of Suppliers: Medium
Specialised chemical intermediates for pheromone synthesis are available from a limited number of sources, giving those suppliers some leverage.
Botanical feedstock prices vary with harvests, although many plant materials are available from multiple producing regions.
Leading pheromone producers are vertically integrated into active ingredient manufacturing, which reduces their dependence on outside suppliers.
Bargaining Power of Buyers: Medium
Large distributors and multinational partners negotiate exclusive arrangements and favourable terms with specialist producers.
Individual growers are fragmented and have limited bargaining power, but they can choose between biochemical, microbial and conventional options.
Food retailers influence product choice indirectly through residue requirements, which can increase demand for specific products.
Threat of Substitutes: High
Conventional synthetic insecticides and fungicides remain cheaper and broader in spectrum for many pest problems.
Microbial pesticides, beneficial insects and other biological controls compete for the same residue-free and organic programmes.
Emerging technologies, such as RNA-based biopesticides and pest-resistant crop varieties, may substitute for biochemical products in some applications.
Intensity of Competitive Rivalry: Medium
Competition among pheromone producers is concentrated in established crops such as apples, grapes, stone fruit and tree nuts.
Product differentiation through dispenser technology, registered pest targets and service limits direct price competition.
Market growth allows multiple competitors to expand without aggressive price-based rivalry.
Threat of new entrants: Medium; Technology and registration barriers offset by simplified data requirements and start-up investment.
Bargaining power of suppliers: Medium; Specialised intermediates and variable botanical feedstocks; vertical integration of leaders.
Bargaining power of buyers: Medium; Large distributors negotiate strongly; growers are fragmented.
Threat of substitutes: High; Synthetic chemistry, microbials and macrobials compete for the same applications.
Intensity of competitive rivalry: Medium; Differentiated products and market growth limit price competition.
Market estimates by geography (2032)
InsightNorth America leads with $318.65M by 2032, while Asia Pacific is projected to grow fastest at a 12.6% CAGR.
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription Plans| REGION | 2022 | 2025 | 2032 | CAGR | SHARE |
|---|---|---|---|---|---|
| North America | $139.54M | $212.57M | $318.65M | 8.6% | 30% |
| Europe | $101.43M | $155.23M | $235.31M | 8.8% | 22% |
| Asia Pacific | $68.23M | $124.85M | $223.68M | 12.6% | 21% |
| Latin America | $84.22M | $140.70M | $233.19M | 10.7% | 22% |
| Middle East & Africa | $16.39M | $27.22M | $46.74M | 11.0% | 4% |
| Total | $409.82M | $660.56M | $1.06B | 9.9% | 100% |
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansTotal Market Size
$1.06B
| APPLICATION | REVENUE ($B) | GROWTH RATE | MARKET PENETRATION |
|---|---|---|---|
| Pheromones & Semiochemicals | $414.57M | 11.8% | 39% |
| Plant Extracts | $381.25M | 10.4% | 36% |
| Others | $261.75M | 7.1% | 25% |
* Revenue projections based on 2025 estimates. Growth rates represent CAGR 2024–2030. Market penetration indicates current adoption rate within addressable market segments.
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansSee plans for professionals or small and medium businesses.
Analytical insights on Biochemical Pesticides Market covering market dynamics, competitive landscape, and strategic outlook.
The Biochemical Pesticides Market market is projected to reach $1.06B by 2032, growing at 9.9% CAGR. The Pheromones & Semiochemicals segment holds the largest share.
The biochemical pesticides market is shaped by the interaction of regulation, grower economics, food-chain requirements and technology. Regulatory pressure on synthetic chemistry and support for low-risk substances are raising demand, while cost and efficacy limitations continue to slow adoption in price-sensitive crops and regions. The following sections assess the major growth factors, drivers, restraints, opportunities, trends and challenges. The impact scores in the growth factor analysis are analyst assessments on a scale of 1 to 10, where a higher score indicates a stronger influence on the market in the period indicated.
Regulatory Pressure on Synthetic Pesticides and Support for Low-Risk Substances
Regulators in major agricultural markets are narrowing the range of synthetic active substances available to growers while creating more favourable pathways for low-risk products. In the European Union, Regulation (EC) No 1107/2009 governs the approval of active substances and, under Article 22, provides for the approval of low-risk active substances, a category into which many semiochemicals and plant extracts fall. The non-renewal of a number of conventional insecticides and fungicides has left gaps in growers' crop protection programmes, particularly in fruit, vegetables and vineyards. In the United States, the Environmental Protection Agency handles biochemical pesticides through a dedicated division and applies tailored data requirements under 40 CFR Part 158, Subpart U, which generally require less toxicology and environmental fate data than conventional pesticides. Brazil adopted a new pesticides law (Law No. 14,785/2023) and a dedicated bioinputs law (Law No. 15,070/2024), and the European Union's Farm to Fork Strategy set a non-binding target of reducing the use and risk of chemical pesticides by 50% by 2030. Together, these measures increase both the need for alternatives and the commercial attractiveness of registering biochemical products.
Food-Chain Residue Requirements and Growth in Organic Production
Food retailers, processors and importing countries increasingly set residue requirements that are stricter than statutory maximum residue limits, often limiting the number of detectable residues or the percentage of the legal limit that may be present. Biochemical pesticides such as pheromones, which are applied in dispensers and do not contact the harvested produce, and plant extracts with short pre-harvest intervals help growers meet these requirements without compromising pest control. Export-oriented horticulture in Latin America, Southern Europe, South Africa and parts of Asia is particularly sensitive to these requirements. Organic production adds a further source of demand: many pheromone and plant-extract products are permitted under organic standards such as the USDA National Organic Program and Japan's Organic JAS, and organic listing has become a common feature of new product launches. As certified organic and residue-managed acreage grows, the number of hectares for which biochemical pesticides are a preferred or required option increases accordingly.
Resistance Management and Integrated Pest Management Adoption
Resistance to synthetic insecticides in key pests, including codling moth, diamondback moth, fall armyworm and various stem borers, has reduced the effectiveness of conventional spray programmes and increased the cost of control. Biochemical pesticides act through modes of action that are not shared with synthetic insecticides, which makes them valuable in resistance management rotations. Mating disruption in particular reduces pest populations over successive seasons when deployed across contiguous areas, and is now an established practice in pome fruit, stone fruit, grapes and tree nuts in North America, Europe, Chile, Argentina and South Africa. Integrated pest management programmes promoted by extension services, crop consultants and food companies explicitly include semiochemicals and botanical products, and national policies in several countries support IPM adoption. This institutional support turns biochemical pesticides from a niche alternative into a standard component of crop protection programmes.
Technology Advances Reducing Cost and Extending Use to Row Crops
Historically, the high cost of synthesising pheromones confined their use to high-value crops. Biomanufacturing approaches, including yeast fermentation and novel synthesis routes developed by companies such as BioPhero (acquired by FMC in 2022) and Provivi, aim to lower production costs to levels compatible with maize, rice, cotton and soybean. New delivery formats, such as sprayable microencapsulated formulations, aerosol dispensers, pheromone gels applied with pressurised applicators, and granules, reduce labour costs and allow application with existing equipment. Product registrations of pheromones for fall armyworm and rice yellow stem borer in Brazil, Mexico, India, Thailand and Australia show that this shift is under way. Investment by large crop protection companies through acquisitions and distribution agreements provides the capital and market access needed to scale these technologies.
Expansion into Large-Acreage Row Crops
Maize, rice, cotton and soybean account for a large share of global insecticide use but a small share of biochemical pesticide use. Lower-cost pheromones for pests such as fall armyworm and rice stem borers open a large addressable market, which is reflected in the Cereals & Grains segment growing at a CAGR of 11.70%, the highest among crop types.
Regulatory Reforms in Emerging Markets
Dedicated legal frameworks for biological inputs, such as Brazil's bioinputs law, and policies promoting natural and low-chemical farming in India and China, create clearer and faster pathways for biochemical products. Companies that build registration portfolios early in these markets can secure a strong position as demand grows.
Combination Products and Integrated Solutions
Combining attractants with natural insecticides in attract-and-kill devices, integrating pheromone dispensers with digital trap monitoring, and bundling biochemical products with microbial and conventional products in programme offerings create higher-value solutions. Partnerships between specialists and major crop protection companies are likely to accelerate the development and distribution of such offerings.
Higher Cost and Narrower Spectrum of Activity
Biochemical pesticides are frequently more expensive per hectare than generic synthetic insecticides and fungicides, and many target a single pest species or a narrow group of pests. Growers facing several pests at once may still need conventional products, which reduces the perceived value of adding a biochemical product to the programme. In price-sensitive markets and crops with thin margins, this cost differential remains a significant barrier.
Performance Variability and Need for Area-Wide Deployment
The efficacy of biochemical products can vary with pest pressure, weather and application timing. Mating disruption performs best when applied across large contiguous areas and can be less effective on small or fragmented plots, at field edges, or where mated females migrate from untreated areas. Plant extracts often have shorter field persistence than synthetic chemistry, requiring more frequent applications. These characteristics demand greater technical knowledge and monitoring from growers.
Registration Complexity and Inconsistent Regulatory Treatment
Although several regulators offer simplified data requirements for biochemical products, registration timelines and costs remain substantial in many countries, and requirements differ from one jurisdiction to another. Smaller manufacturers, which account for much of the innovation in this market, may lack the resources to register products in multiple countries, which limits the global availability of new actives.
Consolidation and Partnership Between Specialists and Majors
Large crop protection companies are building biochemical portfolios through acquisitions and exclusive distribution agreements rather than solely through internal research. FMC's acquisition of BioPhero, Bayer's distribution agreements with M2i, Syngenta's partnership with Provivi and Suterra's acquisition of Vestaron's product lines illustrate this trend, which is expected to continue as companies seek to fill gaps left by the withdrawal of synthetic actives.
Shift to Labour-Saving Delivery Formats
Hand-applied dispensers require significant labour, which is increasingly scarce and costly in many producing regions. Aerosol dispensers that cover larger areas per unit, sprayable formulations and mechanically applied gels or granules are gaining share, and new product launches increasingly focus on reducing the number of application points per hectare.
Challenge of Grower Education and Advisory Support
Biochemical pesticides require pest monitoring, correct timing and, in the case of mating disruption, coordinated deployment across neighbouring farms. In many emerging markets the advisory infrastructure to support such practices is limited, and smallholder fragmentation complicates area-wide approaches. Building advisory capacity through distributors, cooperatives and public extension services remains a key challenge for broader adoption.
Challenge of Feedstock and Quality Consistency for Plant Extracts
Plant-extract products depend on agricultural feedstocks whose active ingredient content varies with growing conditions, harvest and processing. Ensuring consistent product quality and stable supply, as well as meeting registration specifications for the active substance, requires investment in sourcing, standardisation and analytical control.
The biochemical pesticides value chain extends from raw material sourcing through active ingredient production, formulation, registration and distribution to end use by growers. Value is concentrated at the active ingredient and formulation stages, where proprietary synthesis routes, dispenser technology and registrations create barriers to entry.
Raw materials and inputs: Chemical precursors and fermentation feedstocks for synthetic and biomanufactured pheromones; botanical biomass such as neem seed and other plant materials for extracts; polymers, solvents, carriers and packaging materials for dispensers and formulations.
Active ingredient manufacturing: Production of pheromone actives through chemical synthesis or fermentation, and extraction, concentration and standardisation of plant-derived actives. Quality control of isomeric purity and active content is critical at this stage.
Formulation and registration: Conversion of actives into end-use products such as passive dispensers, aerosol dispensers, microencapsulated sprays, gels, emulsifiable concentrates and traps, followed by product registration with national regulators.
Distribution and channels: Sales through multinational crop protection companies under distribution agreements, national and regional agri-input distributors, cooperatives and retailers, and direct sales and technical service to large growers and grower associations.
End users: Commercial growers of fruits, vegetables, cereals and other crops, organic producers, and area-wide pest management programmes, supported by crop consultants and extension services.
North America: In the United States, biochemical pesticides are registered under the Federal Insecticide, Fungicide, and Rodenticide Act (FIFRA) by the Environmental Protection Agency, whose Biopesticides and Pollution Prevention Division within the Office of Pesticide Programs handles biopesticide applications. Data requirements are set out in 40 CFR Part 158, Subpart U, which defines biochemical pesticides and applies tiered testing. Products may also be permitted for organic use under the USDA National Organic Program. In Canada, pesticides are regulated under the Pest Control Products Act by Health Canada. In Mexico, pesticide registration falls under the Federal Commission for the Protection against Sanitary Risks (COFEPRIS) together with agricultural and environmental authorities.
Europe: Active substances and plant protection products are regulated under Regulation (EC) No 1107/2009, with active substances approved at EU level following an EFSA risk assessment and products authorised by Member States. Article 22 provides for low-risk active substances, which benefit from longer approval periods and faster product authorisation. The Sustainable Use of Pesticides Directive (2009/128/EC) requires Member States to promote integrated pest management. A proposed Sustainable Use Regulation was rejected by the European Parliament in November 2023 and withdrawn by the Commission in 2024, although the Farm to Fork pesticide reduction targets continue to be monitored. In Great Britain, the retained version of Regulation (EC) No 1107/2009 is administered by the Health and Safety Executive.
Asia Pacific: In India, pesticides are registered under the Insecticides Act, 1968 by the Registration Committee constituted under the Act, within the Directorate of Plant Protection, Quarantine & Storage. In China, pesticide registration is administered by the Institute for the Control of Agrochemicals, Ministry of Agriculture and Rural Affairs (ICAMA), under the Regulations on Pesticide Administration, with reduced or waivable data requirements available for certain biochemical pesticides. In Japan, registration falls under the Agricultural Chemicals Regulation Act, administered by the Ministry of Agriculture, Forestry and Fisheries. In Australia, the Australian Pesticides and Veterinary Medicines Authority (APVMA) registers agricultural chemical products.
Latin America: Brazil's Law No. 14,785/2023 replaced the previous pesticides law, and Law No. 15,070/2024 established a specific framework for the production, registration, sale and use of bioinputs. In Argentina, plant protection products are registered by the National Agri-Food Health and Quality Service (SENASA).
Middle East & Africa: In South Africa, agricultural remedies are registered under the Fertilizers, Farm Feeds, Agricultural Remedies and Stock Remedies Act, 1947 (Act No. 36 of 1947). In the Gulf states, registration is handled by national authorities such as the UAE Ministry of Climate Change and Environment and the Saudi Ministry of Environment, Water and Agriculture.
International standards: The FAO/WHO International Code of Conduct on Pesticide Management provides guidance on pesticide regulation, and the OECD has issued guidance on registration requirements for pheromones and other semiochemicals used for arthropod pest control.
Jun 2022: FMC Corporation; Acquisition; Agreed to acquire BioPhero ApS, a Danish developer of fermentation-based insect pheromones, for approximately USD 200 Million.
Jul 2022: FMC Corporation; Acquisition; Completed the acquisition of BioPhero ApS, establishing its pheromone platform.
Jul 2022: Bioceres Crop Solutions / Pro Farm Group; Merger; Bioceres completed its all-stock merger with Marrone Bio Innovations, owner of the REGALIA plant-extract product.
Jan 2023: Bayer / M2i Life Sciences; Partnership; Signed an exclusive agreement for Bayer to distribute selected M2i pheromone products in Europe and certain African countries.
Jul 2023: CBC (Biogard); Acquisition; Acquired Bioplanet of Italy, a beneficial insects business, broadening its integrated pest management portfolio.
Sep 2024: Syngenta / Provivi; Partnership; Partnered to bring Provivi pheromone products for rice yellow stem borer (India, Indonesia) and fall armyworm (Thailand) to farmers.
Sep 2024: Suterra; Certification; CheckMate Puffer OFM-O received OMRI listing for use in organic production.
Nov 2024: Provivi / Godrej Agrovet; Partnership; Agreed on distribution of the YSB Eco-Dispenser in India and exclusive Indian rights to the FAW Eco-Dispenser.
Nov 2024: Seipasa; Registration; Spain extended the Pirecris label to stone and pome fruit, berries, apricot and persimmon.
Feb 2025: Syngenta; Acquisition; Agreed to acquire Novartis's repository of natural compounds and strains for agricultural use, along with its natural products team.
Apr 2025: FMC Corporation; Registration; Received its first registration for Sofero Fall pheromone in Brazil, its first pheromone for row crops.
Jun 2025: Shin-Etsu Chemical / Pacific Biocontrol; Registration; Isomate GRB-Z for grape root borer received a FIFRA Section 18 emergency exemption in seven U.S. states.
Jul 2025: Bayer / M2i Life Sciences; Partnership; Expanded the partnership, with Bayer becoming exclusive distributor of M2i pheromone gels in Asia Pacific, Latin America and the U.S.
Aug 2025: Provivi / AgNova; Partnership; Signed a commercial agreement to introduce Pherogen SPOFR for fall armyworm in Australia.
Oct 2025: FMC Corporation; Product launch; Sofero Frugi was approved in Côte d'Ivoire, FMC's first pheromone launch in Europe, the Middle East and Africa.
Oct 2025: Suterra; Registration; BioMagnet Ruby attract-and-kill product for spotted wing drosophila was authorised in California for the 2026 season.
Jan 2026: Pro Farm Group; Ownership change; PFG Holding Corp. won a foreclosure auction for Pro Farm Group's assets; the foreclosure is disputed by Bioceres.
Mar 2026: BASF; Acquisition; Completed the acquisition of AgBiTech, adding biological insect control products to its BioSolutions portfolio.
Apr 2026: Bayer; Registration; Received final marketing authorisation in Spain for Vynyty Citrus, which combines pheromones with natural pyrethrins.
May 2026: Suterra; Acquisition; Acquired Vestaron's product lines (Spear and Basin), active ingredients, R&D pipeline and research assets.
Political
Government policies to reduce chemical pesticide use, such as the EU Farm to Fork targets and national natural farming initiatives, favour biochemical alternatives.
Food security priorities in emerging economies encourage public support for crop protection innovation, including biological inputs.
Trade policies and sanitary requirements of importing countries influence the crop protection choices of export-oriented growers.
Economic
Higher-value specialty crops can absorb the cost of biochemical products more readily than commodity crops.
Farm income volatility and commodity price cycles affect growers' willingness to pay for premium crop protection.
Investment by large agrochemical companies and venture capital funds supports the commercial scale-up of new technologies.
Social
Consumer demand for residue-free and organic produce increases demand from retailers and growers.
Public concern over pesticide effects on pollinators, farm workers and rural communities supports low-toxicity alternatives.
Labour shortages in agriculture favour delivery formats that require fewer applications.
Technological
Biomanufacturing of pheromones through fermentation reduces production costs.
New formulations, such as microencapsulated sprays, aerosol dispensers and gels, improve field persistence and ease of use.
Digital trap monitoring and decision-support tools improve the timing and efficiency of biochemical applications.
Environmental
Biochemical pesticides have target-specific, non-toxic modes of action and minimal effects on beneficial insects.
Climate change is shifting pest ranges and increasing pest pressure, creating new application areas.
Low environmental persistence reduces the risk of soil and water contamination.
Legal
Low-risk and biochemical classifications in the EU and the US provide simplified regulatory pathways.
Registration requirements still differ across countries, increasing the cost of multi-country market entry.
Intellectual property protection for synthesis routes, formulations and dispensers shapes competitive advantage.
Profiles of 105 companies operating in the Biochemical Pesticides Market market, including revenue, employee count, and market positioning where available.
Showing 105 of 105 companies
FMC Corporation is a Philadelphia-based, pure-play crop-protection company and one of the tier-one research-based agrochemical innovators, alongside Syngenta, Bayer, BASF and Corteva. It discovers, develops, manufactures and markets insecticides, herbicides, fungicides and "Plant Health" products (biologicals, crop nutrition, seed treatment) through distributors, retailers, cooperatives and, increasingly, direct-to-grower channels in Brazil. Its economic franchise was built on the diamide insecticides acquired from DuPont in 2017: Rynaxypyr® (~USD 0.8bn of FY2025 sales) and Cyazypyr® (~USD 0.4bn). Both have now lost core patent protection. FMC is therefore in a deep transition. FY2025 revenue fell to USD 3.47bn and the company booked a USD 2.24bn GAAP loss. It has cut the dividend 86%, fallen to junk credit status, and in 2026 raised capital through asset sales, a Corteva licence and a 20% equity stake sale to Tessenderlo Group. The equity case now rests on four new-mode-of-action active ingredients: Isoflex®, fluindapyr, Dodhylex™ and rimisoxafen. --- ### Company's own description (FY2025 10-K, paraphrased) FMC describes itself as a global agricultural sciences company that supplies farmers with innovative solutions to increase the productivity and resilience of their land, and states that it operates in a single business segment. It develops, markets and sells all three major classes of crop-protection chemicals (insecticides, herbicides and fungicides), together with biologicals, crop nutrition and seed-treatment products grouped as "Plant Health." The 10-K calls FMC a "tier-one leader" in agrochemicals, positioned through technology, geographic balance and crop diversity. For 2026 it sets four operational priorities: - strengthening the balance sheet; - improving competitiveness of the core portfolio; - managing the post-patent Rynaxypyr® transition; - supporting the growth of new active ingredients. ### Value-chain position FMC is a discovery-to-formulation innovator that relies heavily on outsourcing. It owns large-scale AI plants in: - Mobile, Alabama (USA) - Manati, Puerto Rico - Jinshan, China - Rønland, Denmark - Panoli, India It also sources "critical intermediates and finished products" largely from third parties in China and India (10-K FY2025 risk factors). Downstream, it sells through: - distributors, retailers and cooperatives in all four regions; - direct sales to large growers in Brazil, an expanding channel cited as a Q4 FY2026 growth driver; - alliance partners, including diamide partners on "cost-plus" contracts. ### Customer types and end-markets Customers are agricultural distributors and retailers, co-ops, large growers (Brazil), and other agrochemical companies that buy diamide AI under supply contracts. End-markets are row crops (soybean, corn, cotton, sugarcane, rice, cereals) and specialty crops (fruits, vegetables, tree nuts). Non-crop uses (pest control, turf) were largely exited with the sale of the Global Specialty Solutions business in November 2024. Demand is seasonal. Northern-hemisphere demand runs March–September, weighting Q1/Q2. Southern-hemisphere demand runs July–February, weighting Q3, Q4 and Q1 (10-K FY2025). ### Independent characterization FMC is a mid-sized research-based agrochemical company. It has a disproportionately concentrated franchise: the diamides were roughly 35% of FY2025 GAAP revenue (USD ~1.2bn of USD 3.47bn). The company is now caught between generic-driven price deflation on its legacy molecules and a still-sub-scale new-AI portfolio (USD ~200M in FY2025). It also faces an unusually leveraged balance sheet for a company of its size. Its strategy has shifted from "growth and returns" (2021–2023) to "survival and re-base" (2025–2026): - monetize IP through partners (Corteva); - shrink the manufacturing footprint (Project Foundation); - exit structurally unprofitable markets (India commercial); - recapitalize via a strategic minority investor (Tessenderlo).
BASF is the world's largest chemical company by sales, built on the Verbund principle of physically and energetically integrated production sites that turn a handful of feedstocks into thousands of products. Since September 2024 it has run under the "Winning Ways" strategy, which splits the portfolio into four core segments (Chemicals, Materials, Industrial Solutions, Nutrition & Care) that stay integrated, and standalone businesses (Agricultural Solutions, Battery Materials, Environmental Catalyst and Metal Solutions, and the now-divested Coatings) that are being monetized or prepared for capital-market options. In 2025 it generated €59.7 billion in sales and €6.6 billion in EBITDA before special items, a cyclical trough. In 2026 it closed the €7.7 billion Coatings transaction, started up its €-multi-billion Zhanjiang Verbund site, raised earnings guidance, and approached Evonik about a takeover. The investment debate is whether structural cost cuts and portfolio proceeds can restore returns above the cost of capital. --- **The company's own description.** BASF describes its purpose with the line "we create chemistry for a sustainable future" (BASF news release boilerplate, 2026) and states its ambition to be the preferred chemical company for enabling customers' green transformation. It reports around 108,000 employees, customers in nearly every sector and almost every country, and sales of around €60 billion in 2025. The portfolio is described as four core segments plus standalone businesses bundled in Surface Technologies and Agricultural Solutions. **Independent characterization.** BASF is best understood as three businesses under one roof: 1. **An integrated commodity and intermediates engine** (Chemicals, the Monomers half of Materials). This is a steam-cracker-to-derivatives chain selling ethylene and propylene derivatives, isocyanates, polyamide precursors and intermediates on spread economics. Earnings are driven by feedstock and energy costs, operating rates and regional supply-demand. It is the most capital-intensive part of the group and the main source of the 2023–2025 earnings decline: Chemicals EBITDA before special items fell from €1,342 million in 2024 to €853 million in 2025 (Factsheet FY2025). 2. **Formulated and performance products** (Performance Materials, Industrial Solutions, Nutrition & Care). These sell on specification and performance to automotive, construction, packaging, consumer goods, pharma and nutrition customers. Margins are steadier but have come under pressure from Asian competition and, in Care Chemicals, from consumer trading-down to private-label products (Factsheet FY2025 commentary). 3. **Standalone franchises** with different industry logic: Agricultural Solutions (crop protection, seeds and traits, digital farming), ECMS (emissions catalysts plus precious-metal trading and recycling) and Battery Materials. Agricultural Solutions is the group's highest-margin segment at 21.7% EBITDA margin before special items in FY2025 and the largest single earnings contributor at €2,081 million. **Revenue model.** Revenue is almost entirely product sales under supply contracts and spot transactions. There is no subscription model of consequence; digital farming (xarvio) and licensing of process technology and catalysts are small. Seeds and traits include royalty and licensing income within Agricultural Solutions, not separately disclosed. Precious-metal trading inflates ECMS sales (€7,978 million in FY2025) with pass-through metal value, which is why BASF quotes group margins both including and excluding metals (12.3% excluding metals in FY2025 per the CFO on the February 27, 2026 call, versus 11.0% reported). **Value chain position.** Upstream to midstream in petrochemicals with captive crackers at Ludwigshafen, Antwerp, Port Arthur (joint venture with TotalEnergies), Nanjing (joint venture with Sinopec) and Zhanjiang; midstream to downstream in engineering plastics, polyurethane systems, dispersions, additives, surfactants and vitamins; branded and channel-driven in agriculture. BASF exited upstream oil and gas operations when Wintershall Dea's E&P business was transferred to Harbour Energy in September 2024. **Customers and end-markets.** BASF serves industrial customers in chemicals and plastics, transportation, construction, consumer goods, agriculture, electronics, energy and resources, and health and nutrition. Intersegment transfers are large (Chemicals transferred €3,432 million internally in FY2025 on €10,055 million of third-party sales), which shows how much of the upstream output feeds BASF's own downstream chains.
Bayer is a German life-science group with three businesses: Crop Science, Pharmaceuticals and Consumer Health. It is the world's largest combined seed, trait and crop-protection supplier, a mid-sized prescription-drug maker, and a top-five self-care company. Fiscal 2025 sales were EUR 45.6 billion. The 2018 purchase of Monsanto brought leading corn and soybean genetics but also glyphosate and PCB litigation, which has consumed well over EUR 10 billion in settlements and produced net losses in 2023, 2024 and 2025. Under CEO Bill Anderson the company has cut management layers, held the dividend at the legal minimum, and concentrated on four priorities: rebuilding the pharma pipeline, containing litigation, reducing debt and improving crop profitability. In 2026 a 7–2 U.S. Supreme Court ruling on federal pre-emption and a proposed USD 7.25 billion class settlement moved the litigation closer to resolution, though the settlement still awaits final court approval. --- **Company's own description.** Bayer describes itself as a global enterprise with core competencies in the life-science fields of health care and nutrition, operating under the mission "Health for all, Hunger for none" (Annual Report 2025; press boilerplate 2026). Bayer AG is a holding company; operations sit in subsidiaries worldwide. In fiscal 2025 the Group had about 88,000 employees, sales of EUR 45.6 billion and R&D expenses of EUR 5.8 billion. **Independent characterisation.** Bayer is best understood as three distinct businesses sharing a balance sheet, a brand and a legal liability. Crop Science (47 percent of FY2025 sales) is an input supplier to farmers. It earns money from proprietary seed and biotech traits, from chemical and biological crop protection, and to a small extent from digital farming subscriptions. Seed and trait revenue carries royalty-like economics: Bayer licenses traits to other seed companies, and two licensing settlements with Corteva lifted results in Q4 2025 and Q1 2026. The business is strongly seasonal, with Northern Hemisphere sales concentrated in the first half and Latin American sales in the second. Pharmaceuticals (39 percent of sales) discovers, develops and sells prescription medicines, concentrated in cardiovascular and renal disease, oncology, women's health and ophthalmology, plus a radiology unit selling contrast agents and injector hardware. Revenue is almost entirely product sales, with some licence income (for example U.S. Xarelto royalties from Johnson & Johnson, and Eylea outside the United States under a collaboration with Regeneron). The division is in the middle of a patent transition: Xarelto and Eylea are declining while Nubeqa and Kerendia are growing quickly. Consumer Health (13 percent of sales) sells non-prescription brands through pharmacies, mass retail and e-commerce. It is a branded consumer-goods model with stable margins and low capital intensity. **Revenue model mix.** Bayer does not disclose a product/service/licensing split. On the evidence of the Annual Report 2025, the large majority of revenue is product sales; licensing income is embedded in Crop Science seed and trait lines and in Pharmaceuticals; subscription revenue (Climate FieldView, radiology software) is immaterial at Group level. An exact percentage split is not publicly disclosed. **Value-chain position.** Bayer is a research-based originator and manufacturer. It owns discovery, development, active-ingredient and finished-product manufacturing, and commercial organisations, and sells through distributors, retailers, wholesalers, hospitals and pharmacies rather than directly to end users in most markets. **Customers and end markets.** Farmers, agricultural retailers and distributors, and seed licensees (Crop Science); wholesalers, hospitals, physicians, pharmacy chains, governments and payers (Pharmaceuticals); pharmacies, supermarkets, drugstores and online retailers (Consumer Health).
DuPont de Nemours today is a focused, roughly USD 7 bn-revenue multi-industry company. It is no longer the diversified chemical conglomerate of its heritage. After a decade of portfolio surgery, the company consists of two segments: **Healthcare & Water Technologies (about 47% of FY2025 sales):** Tyvek® medical packaging and protective garments, specialty medical device components (Spectrum, Donatelle), and the FilmTec™ / Amberlite™ water purification franchise. **Diversified Industrials (about 53%):** Building envelope products (Tyvek® house wrap, Styrofoam™, Corian®) and engineered industrial technologies (Molykote®, Vespel®, Betaseal™/Betaforce™ adhesives, Cyrel® printing plates). The company earns a premium-specialty margin profile: operating EBITDA margin was 23.8% in FY2025, with guidance of about 24.5% for FY2026. Management targets 3–4% organic growth, 150–200 bps of margin expansion and 8–10% adjusted EPS CAGR through 2028, supported by a lightly levered BBB+/Baa1 balance sheet. The principal overhang is legacy PFAS liability, shared with Chemours, Corteva and Qnity under contractual arrangements. The principal opportunity is a cleaner, higher-growth healthcare/water mix and capital redeployment. --- **Company's own description (FY2025 10-K, Item 1).** DuPont describes itself as a leading provider of advanced solutions that improve everyday life across healthcare, water, construction and industrial markets. It emphasizes helping customers advance their technology pipelines, from clean water to medical packaging that enhances safety and performance. It names its competitive strengths as: - proprietary product and process technologies; - robust application-development pipelines; - well-known brands; - customer intimacy; - global manufacturing and local service capability. **Independent characterization.** DuPont is now best understood as a specialty engineered-materials and components company with four businesses of roughly comparable scale: **Business model and revenue model.** - Revenue is overwhelmingly product sales: materials, components, membranes, resins, garments and plates. Some engineered systems and modules are sold in Water. - There is no material subscription or licensing revenue. Trade secrets may be licensed occasionally (10-K, Intellectual Property). - The contract manufacturing and design services of Spectrum and Donatelle (medical devices) add a design-in / build-to-print services element, but are recognized as product revenue. - Seasonality: North American Building Technologies demand peaks in Q2–Q3. **Value-chain position.** DuPont sits mid-stream as a Tier-1/Tier-2 supplier. It converts purchased raw materials (polyolefins, specialty monomers, resins, silicones, polymers) into engineered materials, membranes and components. These are specified into customers' finished products: medical devices, sterile packaging, water plants, building envelopes, aircraft, vehicles and print packaging. **Customer types.** - Medical device OEMs and sterile packaging converters - Biopharma manufacturers - Industrial end users and EPC/OEM water-system integrators - Municipalities and desalination operators (via integrators) - Builders, contractors and distributors (e.g., Corian® distribution through Hallmark and Parksite) - Automotive and EV OEMs and Tier-1s - Aerospace OEMs - Printing and packaging converters Most products are sold through DuPont's own sales organization, with distributors used for some lines (10-K, Distribution). **End markets.** Healthcare (medical devices, packaging, biopharma, PPE), water (industrial, municipal/desalination, life sciences, microelectronics UPW), construction (residential, non-residential, repair/remodel) and industrial (aerospace, automotive/EV, printing and packaging, general industrial).
3 interactive charts drawn from the Biochemical Pesticides Market dataset — market size, regional splits and each segment breakdown. Open one to read its full data table and download it.
Global Biochemical Pesticides Market By Crop Type
Global Biochemical Pesticides Market By Product Type
Global Biochemical Pesticides Market By Region
Powering the world's best teams.
From next-gen startups to established enterprises.
Trusted by forward-thinking businesses
for data-driven intelligence
Co-Founder, Mojave Rail Fabrication Limited
This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job.
Manager, JavolVision
Thanks, I am so happy that we worked together. Maybe we still can work together in the future.
Sales Operations & Pricing Manager, Intel
Thanks. It's been a pleasure working with you, please use me as reference with any other Intel employees.
Sales Leader, Bamberg
We bought your "2025 report" in 2020. Everything is fine and very good.
Account and Business Manager, EFS-Holland BV
Thanks for sending the report it gives us a good global view of the Betaïne market.
Senior Retail Manager, LG Chem
We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.
Management Consultant, Level 21
I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.
Group Product Manager HVAC & Fire Protection GMA, Rockwool
I have been reading the first document or the study, the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!
R&D Director, Seojin
Thanks for your great support. Appreciate it. Well received report. It helps us to understand market well. We're planning other area of survey in the future, let's keep in touch.
Strategy & Business Development Director, Dogan Holding
We got the report in time, we really thank you for your support in this process. I also thank to all of your team as they did a great job.
Historical performance and future projections (2020–2030, USD Billion)
Market Size (USD Million)
